Related Experiment Video
Updated: Jul 4, 2026
Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Artificial intelligence detection of endoscopic moderate-to-severe ulcerative colitis: a novel tool to enhance
Laurie B Grossberg1, Grace Geeganage1, Aditya Mithal2
1Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Background And Aims:
Artificial intelligence (AI) may detect endoscopically active ulcerative colitis (UC) and streamline clinical trial enrollment. Here, we investigate the performance of a commercially available AI model, autoinflammatory bowel disease (AutoIBD)-UC (Virgo Surgical Video Solutions, Inc, San Francisco, Calif, USA), to detect moderate-to-severe UC in colonoscopy videos collected as part of routine clinical practice.
Methods:
AutoIBD-UC was applied to consecutive endoscopy videos between August 30, 2024, and October 17, 2024. Each video received an AutoIBD score (0-1); videos with scores above a predefined confidence threshold were flagged as possible moderate-to-severe UC. Flagged videos and medical records were reviewed to confirm UC diagnosis and grade Mayo endoscopic subscore (MES). Concurrently, research staff retrospectively reviewed all endoscopy reports to identify 3 cohorts: (1) 20 MES ≥2, (2) 20 non-UC inflammation, and (3) 20 screening colonoscopies. Sensitivity and specificity were calculated for all videos screened by AI. Median AutoIBD scores were compared by MES and disease extent.
Results:
AutoIBD-UC was applied to 2273 endoscopy videos. Twenty-one videos were flagged, 10 of which had MES ≥2. AutoIBD-UC flagged 9 of 20 videos in cohort 1 and all MES 3 videos. More procedures with extensive (4 of 8) or left-sided disease (5 of 7) were flagged compared with those with proctitis (0 of 5). Median AutoIBD-UC scores differed between MES 2 (0.437; interquartile range [IQR], 0.270-0.571) and MES 3 (0.690; IQR, 0.607-0.765; P = .006), and by disease extent: proctitis (0.224; IQR, 0.193-0.270), left-sided (0.571; IQR, 0.554-0.603), and extensive (0.506; IQR, 0.408-0.598; P = .021). The sensitivity of AutoIBD-UC was 0.47, and the specificity was 0.99.
Conclusions:
AutoIBD-UC accurately detects moderate-to-severe UC with moderate sensitivity and high specificity. Larger studies are necessary to evaluate AutoIBD-UC's utility as a recruitment aid compared to standard practice.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):